CN Patent

CN102469781A — 用静脉内布洛芬治疗患者

Assigned to Cumberland Pharmaceuticals Inc · Expires 2012-05-23 · 14y expired

What this patent protects

治疗有相应需要的患者的方法，所述方法包括向危重疾病患者施用有效治疗选自疼痛、炎症和发热的患者的至少一种病症并在给药间隔期间提供对该患者的平均动脉压的临床相关作用的量的包含布洛芬的静脉内药物组合物，所述临床相关作用包括平均动脉压没有升高或没有统计学显著地升高。

USPTO Abstract

治疗有相应需要的患者的方法，所述方法包括向危重疾病患者施用有效治疗选自疼痛、炎症和发热的患者的至少一种病症并在给药间隔期间提供对该患者的平均动脉压的临床相关作用的量的包含布洛芬的静脉内药物组合物，所述临床相关作用包括平均动脉压没有升高或没有统计学显著地升高。

Drugs covered by this patent

Patent Metadata

Patent number
CN102469781A
Jurisdiction
CN
Classification
—
Expires
2012-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Cumberland Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.